700 patients110,866 observations180 daysLIVE

Simulate first, then a human deploys. LIFE OS never deploys on its own.

Interventions

Synthetic demo data

What is working among similar responders

Outcomes of every action among the 284 trajectories most similar to P-02250. Sorted by evidence weight (n × improved share).

n = accepted instances

Action	n	Improved	Mean effect	Onset	This patient
GI-04 GI Support Protocol	64	77%	−22%	8 d	eligible · 70%	Simulate
ME-01 Monitoring Escalation	42	100%	−3%	3 d	eligible · 75%	Simulate
NP-02 Dietary Support Protocol	32	59%	−15%	10 d	eligible · 75%	Simulate
SC-12 Supportive Compound	26	69%	−14%	6 d	eligible · 75%	Simulate
CR-01 Clinician Review	7	100%	−19%	5 d	eligible · 75%	Simulate
DT-01 Dosing / Timing Recommendation	5	80%	−12%	5 d	eligible · 75%	Simulate
HY-01 Hydration Protocol	5	60%	−14%	4 d	eligible · 75%	Simulate
BR-03 Behavioural Recommendation	2	0%	−2%	7 d	eligible · 75%	Simulate

Create intervention

Cohort: 1 patients · patient P-02250

Before deployment

simulation

Save cohort Cancel

Campaigns

Nothing deployed yet in META-24.

Action catalogue

GI-04Nutritional protocol

GI Support Protocol GI-04

symptom −31% · persistence +17% · onset 8 d

SC-12Supportive compound

Supportive Compound SC-12

symptom −18% · persistence +11% · onset 6 d

NP-02Nutritional protocol

Dietary Support Protocol NP-02

symptom −28% · persistence +9% · onset 10 d

HY-01Hydration protocol

Hydration Protocol HY-01

symptom −14% · persistence +6% · onset 4 d

ME-01Monitoring escalation

Monitoring Escalation ME-01

symptom −5% · persistence +12% · onset 3 d

BR-03Behavioural recommendation

Behavioural Recommendation BR-03

symptom −10% · persistence +10% · onset 7 d

CR-01Clinician review

Clinician Review CR-01

symptom −12% · persistence +15% · onset 5 d

AD-05Adherence support

Adherence Support AD-05

symptom −2% · persistence +14% · onset 5 d

DT-01Dosing / timing recommendation

Dosing / Timing Recommendation DT-01

symptom −16% · persistence +8% · onset 5 d